Effects of Soft Tissue Lengthening on Gait in Children With Spasticity

Status Completed

Clinical Trial Summary

This research project is being conducted to investigate changes in secondary impairments, functional mobility skills, and gait variables in children with spasticity following selective percutaneous myofascial lengthening. The research project proposed here will be the first to use instrumented three-dimensional motion analysis to investigate the effects of selective percutaneous myofascial lengthening on gait kinematics and kinetics. The objectives of the study are to:

1. Compare gait kinematics and kinetics in children and young adults with lower extremity spasticity before and after selective percutaneous myofascial lengthening to determine the effects of this procedure on functional mobility.

2. Identify changes in impairments and activity limitations following selective percutaneous myofascial lengthening .

3. Identify changes in a family or caregivers perceived quality of life after their child's selective percutaneous myofascial lengthening .

The aim of this study is to identify and describe the specific changes in secondary musculoskeletal impairments, activity limitations, and gait kinematics and kinetics after a selective percutaneous myofascial lengthening procedure. Gait kinematics and kinetics includes the motion of joints and body segments, and force and power, at each lower extremity joint, respectively. The results of this study will provide preliminary information on how this form of soft tissue lengthening affects functional mobility skills in children with spasticity. The study is expected to run for two years and the primary study endpoint is when participants have completed their second post- operative data collection session.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Muscle Spasticity

Clinical Trial Details

NCT number	NCT04090892
Study type	Observational
Source	University of Texas Southwestern Medical Center
Contact
Status	Completed
Phase
Start date	May 10, 2016
Completion date	January 31, 2017

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04535479` - Dry Needling for Spasticity in Stroke	N/A
Completed	`NCT02907775` - Multi-channel Stimulation for Post Stroke Spasticity (MUSTS)	N/A
Recruiting	`NCT04530955` - Transitioning to a Valve-Gated Intrathecal Drug Delivery System (IDDS)	N/A
Active, not recruiting	`NCT03521076` - Randomized Controlled Trial of Virtual Reality	N/A
Completed	`NCT03080454` - The Role of Trans-spinal Direct Current Stimulation (tsDCS) in Treating Patients With Hand Spasticity After Stroke	Phase 1/Phase 2
Completed	`NCT02546999` - Does Botulinum Toxin A Make Walking Easier in Children With Cerebral Palsy?	Phase 4
Active, not recruiting	`NCT01041157` - Botulinum Toxin Injection Efficiency	Phase 1
Terminated	`NCT00532532` - Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis	Phase 2
Terminated	`NCT00531466` - Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury	Phase 2
Completed	`NCT00535938` - MDs on Botox Utility (MOBILITY)	N/A
Completed	`NCT05546190` - A Study to Collect Participants Experience of Living With Adult Upper Limb (AUL) Spasticity and to Assess the Arm Activity Measure (ArmA)
Recruiting	`NCT06117020` - Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals	Phase 1
Completed	`NCT01603628` - BOTOX® Treatment in Pediatric Lower Limb Spasticity	Phase 3
Completed	`NCT05510726` - Quantitative Evaluation of Muscle Stiffness in Neurological Patients With Muscle Overactivity
Not yet recruiting	`NCT04378946` - Error Augmentation Motor Learning Training Approach in Stroke Patients	N/A
Completed	`NCT01603615` - BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity	Phase 3
Completed	`NCT01251380` - Dysport® Pediatric Lower Limb Spasticity Follow-on Study	Phase 3
Completed	`NCT00549783` - BOTOX® Economic Spasticity Trial (BEST)	Phase 4
Completed	`NCT00210431` - Post Marketing Surveillance Study of Dysport
Completed	`NCT00076687` - Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function	Phase 2